These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 23968651

  • 41. Clinical diagnosis and diagnostic criteria of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
    Tolosa E, Valldeoriola F, Marti MJ.
    J Neural Transm Suppl; 1994; 42():15-31. PubMed ID: 7964684
    [Abstract] [Full Text] [Related]

  • 42. Accuracy of clinical diagnosis of progressive supranuclear palsy.
    Osaki Y, Ben-Shlomo Y, Lees AJ, Daniel SE, Colosimo C, Wenning G, Quinn N.
    Mov Disord; 2004 Feb; 19(2):181-9. PubMed ID: 14978673
    [Abstract] [Full Text] [Related]

  • 43. Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism.
    Assogna F, Pellicano C, Cravello L, Savini C, Macchiusi L, Pierantozzi M, Stefani A, Mercuri B, Caltagirone C, Pontieri FE, Spalletta G.
    Brain Behav; 2019 Dec; 9(12):e01448. PubMed ID: 31743601
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability.
    Shoeibi A, Litvan I, Tolosa E, Ser TD, Lee E, TAUROS Investigators.
    Parkinsonism Relat Disord; 2019 Sep; 66():87-93. PubMed ID: 31307919
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Frontal deficits differentiate progressive supranuclear palsy from Parkinson's disease.
    Lee YE, Williams DR, Anderson JF.
    J Neuropsychol; 2016 Mar; 10(1):1-14. PubMed ID: 25223526
    [Abstract] [Full Text] [Related]

  • 48. Which ante mortem clinical features predict progressive supranuclear palsy pathology?
    Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Whitwell JL, Antonini A, Bhatia KP, Bordelon Y, Corvol JC, Colosimo C, Dodel R, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris H, Nestor P, Oertel WH, Rabinovici GD, Rowe JB, van Eimeren T, Wenning GK, Boxer A, Golbe LI, Litvan I, Stamelou M, Höglinger GU, Movement Disorder Society-Endorsed PSP Study Group.
    Mov Disord; 2017 Jul; 32(7):995-1005. PubMed ID: 28500752
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Natural clinical course of progressive supranuclear palsy in Chinese patients in Hong Kong.
    Shea YF, Shum ACK, Lee SC, Chiu PKC, Leung KS, Kwan YK, Mok FCK, Chan FHW.
    Hong Kong Med J; 2019 Dec; 25(6):444-452. PubMed ID: 31796642
    [Abstract] [Full Text] [Related]

  • 52. [Cognitive deficits in progressive supranuclear palsy].
    Kułakowska A, Pyd E, Halicka D, Pogorzelski R, Drozdowski W.
    Neurol Neurochir Pol; 2003 Dec; 37 Suppl 5():203-10. PubMed ID: 15098348
    [Abstract] [Full Text] [Related]

  • 53. Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: a prospective natural history study.
    Jecmenica-Lukic M, Petrovic IN, Pekmezovic T, Kostic VS.
    J Neurol; 2014 Aug; 261(8):1575-83. PubMed ID: 24888315
    [Abstract] [Full Text] [Related]

  • 54. Vestibular symptoms as the presenting feature of progressive supranuclear palsy.
    Haggstrom L, Brew B, Sutton I, Tisch S.
    J Clin Neurosci; 2018 Apr; 50():74-76. PubMed ID: 29398194
    [Abstract] [Full Text] [Related]

  • 55. [Prognosis of patients with progressive supranuclear palsy].
    Aiba I, Saito Y, Tamakoshi A, Matsuoka Y.
    Rinsho Shinkeigaku; 2005 Aug; 45(8):565-70. PubMed ID: 16180703
    [Abstract] [Full Text] [Related]

  • 56. Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy.
    Schofield EC, Hodges JR, Macdonald V, Cordato NJ, Kril JJ, Halliday GM.
    Mov Disord; 2011 Feb 01; 26(2):256-63. PubMed ID: 21412832
    [Abstract] [Full Text] [Related]

  • 57. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
    Lannuzel A, Höglinger GU, Verhaeghe S, Gire L, Belson S, Escobar-Khondiker M, Poullain P, Oertel WH, Hirsch EC, Dubois B, Ruberg M.
    Brain; 2007 Mar 01; 130(Pt 3):816-27. PubMed ID: 17303592
    [Abstract] [Full Text] [Related]

  • 58. Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study.
    Kanazawa M, Shimohata T, Toyoshima Y, Tada M, Kakita A, Morita T, Ozawa T, Takahashi H, Nishizawa M.
    Mov Disord; 2009 Jul 15; 24(9):1312-8. PubMed ID: 19412943
    [Abstract] [Full Text] [Related]

  • 59. Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer's disease pathology.
    Rippon GA, Boeve BF, Parisi JE, Dickson DW, Ivnik RI, Jack CR, Hutton M, Baker M, Josephs KA, Knopman DS, Petersen RC.
    Neurocase; 2005 Jun 15; 11(3):204-11. PubMed ID: 16006341
    [Abstract] [Full Text] [Related]

  • 60. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.
    Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS.
    Neurology; 1996 Jul 15; 47(1):1-9. PubMed ID: 8710059
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.